We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Primary Health Properties plc (PHP) Ordinary Shares 12.5p

Sell:136.20p Buy:136.40p 0 Change: No change
FTSE 250:0.28%
Market closed Prices as at close on 1 July 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Change: No change
Market closed Prices as at close on 1 July 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Change: No change
Market closed Prices as at close on 1 July 2022 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Primary Health Properties PLC is a United Kingdom-based real estate investment trust (REIT) and an investor in primary healthcare accommodation across the United Kingdom and Ireland. The Company invests in healthcare real estate let on long-term leases, backed by underlying covenants. The majority of its healthcare facilities are GP surgeries, with other properties let to NHS organizations, HSE in Ireland, pharmacies and dentists. The Company invest in flexible, modern properties for local primary healthcare, let on long term leases with a property portfolio of 521 assets in the United Kingdom and Ireland. The Company's property portfolio includes Cleethorpes Primary Care Centre, Oswestry Primary Care Centre, Belmont Medical Centre, Forestside Medical Practice, Harrowby Lane Surgery, Cornerways Medical Centre, Mile Oak Medical Centre, Oaklands Health Centre, Charnock Health Primary Care Centre, Victoria Central Health Centre, Greenmoss Medical Centre and Boothtown Medical Centre.

Contact details

5th Fl, Greener House, 66-68 Haymarket
United Kingdom
+44 (020) 71045599

Important dates

Future events
Quarterly dividend payment date 19 August 2022 19/08/22
Interim results 28 July 2022 28/07/22
Interim results 27 July 2022 27/07/22
Quarterly ex-dividend date 07 July 2022 07/07/22
Past events
Quarterly dividend payment date 20 May 2022 20/05/22
AGM 27 April 2022 27/04/22
Trading Announcement 27 April 2022 27/04/22
Quarterly ex-dividend date 31 March 2022 31/03/22
Annual report 09 March 2022 09/03/22
Quarterly dividend payment date 25 February 2022 25/02/22
Final results 16 February 2022 16/02/22
Quarterly ex-dividend date 13 January 2022 13/01/22
Quarterly dividend payment date 26 November 2021 26/11/21
Quarterly ex-dividend date 14 October 2021 14/10/21
Quarterly dividend payment date 20 August 2021 20/08/21
Interim results 28 July 2021 28/07/21
Quarterly ex-dividend date 08 July 2021 08/07/21

General stock information

Market cap:
£1.82 billion
Shares in issue:
1.33 billion
Real Estate Investment Trusts
London Stock Exchange
Sterling pence
FTSE 250,FTSE 350,FTSE All Share,FTSE 350 Higher Yield

Key personnel

  • Harry Hyman
    Chief Executive Officer, Executive Director
  • Richard Howell
    Chief Financial Officer, Executive Director
  • Chris Santer
    Chief Investment Officer
  • David Austin
    Director of Asset Management
  • David Bateman
    Investment Director
  • Liam Cleary
    Director of Commercial Finance and Financial Reporting
  • Tony Coke
    Director of Development
  • Oliver Goodman
    Director of Rent Reviews and Valuation
  • Jesse Putzel
    Director - ESG
  • Michelle Whitfield
    Director of Operations and Sustainability

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.